A soft coral-derived compound, 11-dehydrosinulariolide, induces G2/M cell cycle arrest and apoptosis in small cell lung cancer

Yu Chao Lin, Jui Hsin Su, Shih Chao Lin, Chia Che Chang, Te Chun Hsia, Yu Tang Tung, Chi Chien Lin

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

11-Dehydrosinulariolide, an active compound that is isolated from the cultured soft coral Sinularia flexibilis, has been suggested to show anti-tumor biological characteristics according to previous studies. However, its potential effect on small cell lung cancer (SCLC) remains unknown. The present study investigates the underlying mechanism for the treatment of SCLC in vitro and in vivo. Cell viability was examined using the methyl-thiazol-diphenyl-tetrazolium (MTT) assay. Flow cytometry was applied to evaluate cell cycle distribution and apoptosis. The expression of proteins related to the cell cycle and apoptosis was analyzed by Western blot analysis. Additionally, an in vivo study was performed to determine the anti-SCLC effect on an H1688 subcutaneous tumor in a BALB/c nude mouse model. 11-Dehydrosinulariolide inhibited cell growth, triggered G2/M arrest and induced H1688 cell apoptosis in a dose- and time-dependent manner. Additionally, 11-dehydrosinulariolide caused the accumulation of p53 and Bax, accompanied by the activation of DNA damage-inducing kinases, including ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2). Moreover, 11-dehydrosinulariolide increased the activity of caspase-3 and -7, suggesting that caspases are involved in 11-dehydrosinulariolide-induced apoptosis. 11-Dehydrosinulariolide also increased the level of tumor suppressor phosphatase and tensin homolog (PTEN) and inhibited the expression of phosphorylated Akt. In the in vivo study, the intraperitoneal injection of 11-dehydrosinulariolide at a dosage of 10 mg/kg significantly inhibited tumor growth compared with the control treatment. Together, the data indicate that 11-dehydrosinulariolide induces G (2)/M cell cycle arrest and apoptosis through various cellular processes, including the upregulation of p53 and Bax, activation of ATM and Chk2, activation of caspase-3 and -7, and accumulation of PTEN, leading to inhibition of the Akt pathway. These findings suggest that 11-dehydrosinulariolide might serve as a promising chemotherapy drug in the treatment of SCLC.
原文英語
文章編號479
期刊Marine Drugs
16
發行號12
DOIs
出版狀態已發佈 - 十一月 30 2018

指紋

G2 Phase Cell Cycle Checkpoints
Anthozoa
Small Cell Lung Carcinoma
Apoptosis
Caspase 7
Ataxia Telangiectasia
Phosphoric Monoester Hydrolases
Caspase 3
Neoplasms
Checkpoint Kinase 2
Cell Cycle
11-dehydrosinulariolide
Growth
Caspases
Cell Cycle Checkpoints
Intraperitoneal Injections
Nude Mice
DNA Damage
Cell Survival
Flow Cytometry

ASJC Scopus subject areas

  • Drug Discovery

引用此文

A soft coral-derived compound, 11-dehydrosinulariolide, induces G2/M cell cycle arrest and apoptosis in small cell lung cancer. / Lin, Yu Chao; Su, Jui Hsin; Lin, Shih Chao; Chang, Chia Che; Hsia, Te Chun; Tung, Yu Tang; Lin, Chi Chien.

於: Marine Drugs, 卷 16, 編號 12, 479, 30.11.2018.

研究成果: 雜誌貢獻文章

Lin, Yu Chao ; Su, Jui Hsin ; Lin, Shih Chao ; Chang, Chia Che ; Hsia, Te Chun ; Tung, Yu Tang ; Lin, Chi Chien. / A soft coral-derived compound, 11-dehydrosinulariolide, induces G2/M cell cycle arrest and apoptosis in small cell lung cancer. 於: Marine Drugs. 2018 ; 卷 16, 編號 12.
@article{b8644a21d14d4e01be06dc4b01a789de,
title = "A soft coral-derived compound, 11-dehydrosinulariolide, induces G2/M cell cycle arrest and apoptosis in small cell lung cancer",
abstract = "11-Dehydrosinulariolide, an active compound that is isolated from the cultured soft coral Sinularia flexibilis, has been suggested to show anti-tumor biological characteristics according to previous studies. However, its potential effect on small cell lung cancer (SCLC) remains unknown. The present study investigates the underlying mechanism for the treatment of SCLC in vitro and in vivo. Cell viability was examined using the methyl-thiazol-diphenyl-tetrazolium (MTT) assay. Flow cytometry was applied to evaluate cell cycle distribution and apoptosis. The expression of proteins related to the cell cycle and apoptosis was analyzed by Western blot analysis. Additionally, an in vivo study was performed to determine the anti-SCLC effect on an H1688 subcutaneous tumor in a BALB/c nude mouse model. 11-Dehydrosinulariolide inhibited cell growth, triggered G2/M arrest and induced H1688 cell apoptosis in a dose- and time-dependent manner. Additionally, 11-dehydrosinulariolide caused the accumulation of p53 and Bax, accompanied by the activation of DNA damage-inducing kinases, including ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2). Moreover, 11-dehydrosinulariolide increased the activity of caspase-3 and -7, suggesting that caspases are involved in 11-dehydrosinulariolide-induced apoptosis. 11-Dehydrosinulariolide also increased the level of tumor suppressor phosphatase and tensin homolog (PTEN) and inhibited the expression of phosphorylated Akt. In the in vivo study, the intraperitoneal injection of 11-dehydrosinulariolide at a dosage of 10 mg/kg significantly inhibited tumor growth compared with the control treatment. Together, the data indicate that 11-dehydrosinulariolide induces G (2)/M cell cycle arrest and apoptosis through various cellular processes, including the upregulation of p53 and Bax, activation of ATM and Chk2, activation of caspase-3 and -7, and accumulation of PTEN, leading to inhibition of the Akt pathway. These findings suggest that 11-dehydrosinulariolide might serve as a promising chemotherapy drug in the treatment of SCLC.",
keywords = "11-dehydrosinulariolide, Apoptosis, Cell cycle arrest, Small cell lung cancer, Soft coral",
author = "Lin, {Yu Chao} and Su, {Jui Hsin} and Lin, {Shih Chao} and Chang, {Chia Che} and Hsia, {Te Chun} and Tung, {Yu Tang} and Lin, {Chi Chien}",
year = "2018",
month = "11",
day = "30",
doi = "10.3390/md16120479",
language = "English",
volume = "16",
journal = "Marine Drugs",
issn = "1660-3397",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - A soft coral-derived compound, 11-dehydrosinulariolide, induces G2/M cell cycle arrest and apoptosis in small cell lung cancer

AU - Lin, Yu Chao

AU - Su, Jui Hsin

AU - Lin, Shih Chao

AU - Chang, Chia Che

AU - Hsia, Te Chun

AU - Tung, Yu Tang

AU - Lin, Chi Chien

PY - 2018/11/30

Y1 - 2018/11/30

N2 - 11-Dehydrosinulariolide, an active compound that is isolated from the cultured soft coral Sinularia flexibilis, has been suggested to show anti-tumor biological characteristics according to previous studies. However, its potential effect on small cell lung cancer (SCLC) remains unknown. The present study investigates the underlying mechanism for the treatment of SCLC in vitro and in vivo. Cell viability was examined using the methyl-thiazol-diphenyl-tetrazolium (MTT) assay. Flow cytometry was applied to evaluate cell cycle distribution and apoptosis. The expression of proteins related to the cell cycle and apoptosis was analyzed by Western blot analysis. Additionally, an in vivo study was performed to determine the anti-SCLC effect on an H1688 subcutaneous tumor in a BALB/c nude mouse model. 11-Dehydrosinulariolide inhibited cell growth, triggered G2/M arrest and induced H1688 cell apoptosis in a dose- and time-dependent manner. Additionally, 11-dehydrosinulariolide caused the accumulation of p53 and Bax, accompanied by the activation of DNA damage-inducing kinases, including ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2). Moreover, 11-dehydrosinulariolide increased the activity of caspase-3 and -7, suggesting that caspases are involved in 11-dehydrosinulariolide-induced apoptosis. 11-Dehydrosinulariolide also increased the level of tumor suppressor phosphatase and tensin homolog (PTEN) and inhibited the expression of phosphorylated Akt. In the in vivo study, the intraperitoneal injection of 11-dehydrosinulariolide at a dosage of 10 mg/kg significantly inhibited tumor growth compared with the control treatment. Together, the data indicate that 11-dehydrosinulariolide induces G (2)/M cell cycle arrest and apoptosis through various cellular processes, including the upregulation of p53 and Bax, activation of ATM and Chk2, activation of caspase-3 and -7, and accumulation of PTEN, leading to inhibition of the Akt pathway. These findings suggest that 11-dehydrosinulariolide might serve as a promising chemotherapy drug in the treatment of SCLC.

AB - 11-Dehydrosinulariolide, an active compound that is isolated from the cultured soft coral Sinularia flexibilis, has been suggested to show anti-tumor biological characteristics according to previous studies. However, its potential effect on small cell lung cancer (SCLC) remains unknown. The present study investigates the underlying mechanism for the treatment of SCLC in vitro and in vivo. Cell viability was examined using the methyl-thiazol-diphenyl-tetrazolium (MTT) assay. Flow cytometry was applied to evaluate cell cycle distribution and apoptosis. The expression of proteins related to the cell cycle and apoptosis was analyzed by Western blot analysis. Additionally, an in vivo study was performed to determine the anti-SCLC effect on an H1688 subcutaneous tumor in a BALB/c nude mouse model. 11-Dehydrosinulariolide inhibited cell growth, triggered G2/M arrest and induced H1688 cell apoptosis in a dose- and time-dependent manner. Additionally, 11-dehydrosinulariolide caused the accumulation of p53 and Bax, accompanied by the activation of DNA damage-inducing kinases, including ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2). Moreover, 11-dehydrosinulariolide increased the activity of caspase-3 and -7, suggesting that caspases are involved in 11-dehydrosinulariolide-induced apoptosis. 11-Dehydrosinulariolide also increased the level of tumor suppressor phosphatase and tensin homolog (PTEN) and inhibited the expression of phosphorylated Akt. In the in vivo study, the intraperitoneal injection of 11-dehydrosinulariolide at a dosage of 10 mg/kg significantly inhibited tumor growth compared with the control treatment. Together, the data indicate that 11-dehydrosinulariolide induces G (2)/M cell cycle arrest and apoptosis through various cellular processes, including the upregulation of p53 and Bax, activation of ATM and Chk2, activation of caspase-3 and -7, and accumulation of PTEN, leading to inhibition of the Akt pathway. These findings suggest that 11-dehydrosinulariolide might serve as a promising chemotherapy drug in the treatment of SCLC.

KW - 11-dehydrosinulariolide

KW - Apoptosis

KW - Cell cycle arrest

KW - Small cell lung cancer

KW - Soft coral

UR - http://www.scopus.com/inward/record.url?scp=85057716193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057716193&partnerID=8YFLogxK

U2 - 10.3390/md16120479

DO - 10.3390/md16120479

M3 - Article

AN - SCOPUS:85057716193

VL - 16

JO - Marine Drugs

JF - Marine Drugs

SN - 1660-3397

IS - 12

M1 - 479

ER -